Rigel Pharmaceuticals Inc (RIGL) reports a 68% increase in net product sales and outlines promising developments for 2025.

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and ...

SOUTH SAN FRANCISCO, Calif. (AP) — SOUTH SAN FRANCISCO, Calif. (AP) — Rigel Pharmaceuticals Inc. (RIGL) on Tuesday reported first-quarter profit of $11.4 million. The South San Francisco, ...

Analysts are estimating that Rigel Pharmaceuticals will report an earnings per share (EPS) of $0.09. Investors in Rigel ...

Q1 2025 Management View CEO Raul Rodriguez highlighted "year-over-year net product sales growth of 68%" and total revenue of $53.3 million for Q1 2025. He noted that Rigel achieved $11.4 million in ...

A 10-week-old puppy is safe and on the road to recovery after being found abandoned in a crate along a Lamar County road ...

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that it will report its first quarter 2025 financial results after ...

SOUTH SAN FRANCISCO, Calif., April 29, 2025 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that it will report its first quarter 2025 financial results after market ...

LAMAR COUNTY, Miss. (WDAM) - A section of West Fourth Street in Lamar Countify was blocked for about 90 minutes Sunday after ...

The theme of this year's Matariki holiday highlights the star Puanga or Rigel, which is observed in the astronomical ...

Five suspects were arrested after severing a victim's finger in the latest "wrench attack" involving attempts at crypto ...

Rigel Pharmaceuticals (RIGL) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates ...